Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY
Volume 58, Issue 4, Pages 405-412
Publisher
Springer Science and Business Media LLC
Online
2023-02-22
DOI
10.1007/s00535-023-01968-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
- (2022) Sarah Blach et al. Lancet Gastroenterology & Hepatology
- The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C
- (2022) Hitoshi Tajiri et al. Scientific Reports
- Treatment failure with DAA therapy: importance of resistance
- (2021) Christoph Sarrazin JOURNAL OF HEPATOLOGY
- Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in children with chronic hepatitis C virus: part 2 of the DORA study
- (2021) Maureen M Jonas et al. HEPATOLOGY
- Road to elimination of HCV: Clinical challenges in HCV management
- (2021) C. Nelson Hayes et al. LIVER INTERNATIONAL
- Systematic review with meta-analysis: impact of baseline resistance-associated substitutions on the efficacy of glecaprevir/pibrentasvir among chronic hepatitis C patients
- (2020) Achintya D. Singh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis
- (2020) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Global prevalence of hepatitis C virus in children in 2018: a modelling study
- (2020) Jonathan Schmelzer et al. Lancet Gastroenterology & Hepatology
- Comparison of Recommendations for Treatment of Chronic Hepatitis C Virus Infection in Children and Adolescents
- (2020) Giuseppe Indolfi et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Efficacy of Sofosbuvir/Ledipasvir in Adolescents With Chronic Hepatitis C Genotypes 1, 3, and 4
- (2020) Daniele Serranti et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir
- (2019) Hayato Uemura et al. JOURNAL OF GASTROENTEROLOGY
- Initial- and re-treatment effectiveness of glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C virus-genotype 1/2/3 infections
- (2019) Hitomi Sezaki et al. JOURNAL OF GASTROENTEROLOGY
- Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents with Chronic HCV : Part 1 of the DORA Study
- (2019) Maureen M Jonas et al. HEPATOLOGY
- Ledipasvir−Sofosbuvir for 12 Weeks in Children 3 to
- (2019) Kathleen B. Schwarz et al. HEPATOLOGY
- Magnitude and Kinetics of Decrease in Liver Stiffness After Antiviral Therapy in Patients With Chronic Hepatitis C: A Systematic Review and Meta-analysis
- (2018) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
- (2018) Namiki Izumi et al. Hepatology International
- Treatment of Chronic Hepatitis C Virus Infection in Children
- (2018) Giuseppe Indolfi et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection
- (2017) William F. Balistreri et al. HEPATOLOGY
- Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan
- (2017) Tatsuki Mizuochi et al. JOURNAL OF GASTROENTEROLOGY
- Serum WFA+-M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C
- (2015) K. Ura et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection
- (2014) Mika Miura et al. HEPATOLOGY RESEARCH
- Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial
- (2012) Maureen M. Jonas et al. HEPATOLOGY
- Analysis of viral amino acids sequences and the IL28B SNP influencing the development of hepatocellular carcinoma in chronic hepatitis C
- (2011) Mika Miura et al. Hepatology International
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search